STOCK TITAN

Ares Capital SEC Filings

ARCC NASDAQ

Welcome to our dedicated page for Ares Capital SEC filings (Ticker: ARCC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Ares Capital Corporation (ARCC) SEC filings page provides access to the company’s official regulatory disclosures as a publicly traded business development company (BDC). As a specialty finance firm focused on direct loans and other investments in private middle market companies in the United States, Ares Capital uses its SEC reports to detail portfolio composition, investment activity, capital structure, and material corporate events.

Through this page, readers can review annual reports on Form 10-K and quarterly reports on Form 10-Q, which include information on portfolio investments at fair value, total assets, stockholders’ equity, net assets per share, debt-to-equity ratios, weighted average yields, asset class mix, and loans on non-accrual status. These filings also discuss liquidity and capital resources, including senior secured revolving credit facilities, revolving funding facilities, and unsecured notes.

Ares Capital’s current reports on Form 8-K disclose material events such as the pricing and issuance of unsecured notes, amendments to credit facilities, quarterly financial results, dividend declarations, and outcomes of stockholder meetings. For example, 8-K filings describe supplemental indentures for new note offerings, covenants tied to BDC regulatory requirements, and change of control repurchase provisions. They also report Board decisions on quarterly cash dividends and authorizations to issue common stock subject to specified conditions.

Investors can also use this page to locate information relevant to debt investors and governance, including details on interest rate swaps associated with note offerings, voting results from special meetings, and references to sections of Ares Capital’s 10-Q and 10-K that explain portfolio grading and non-accrual loans. Real-time updates from the SEC’s EDGAR system, combined with AI-powered summaries, help readers quickly understand the key points of lengthy filings, such as how new financings affect leverage, available liquidity, and the company’s capacity to pursue its middle market lending objectives.

Rhea-AI Summary

Ares Capital Corporation is offering senior unsecured notes under a preliminary prospectus supplement that supplements its May 1, 2024 prospectus. The supplement describes the notes’ basic terms including semiannual interest payments, optional redemptions, and a holder repurchase right upon a Change of Control Repurchase Event.

The document states the notes will rank pari passu with other unsecured unsubordinated indebtedness, are unsecured and structurally subordinated to subsidiary indebtedness, and that net proceeds are expected to be used, in whole or in part, to repay borrowings under identified revolving and funding facilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

The board of Ares Capital Corporation is asking common stockholders to authorize the Company to, with board approval, sell or otherwise issue up to 25% of then outstanding common stock at prices below the then-current net asset value per share. The authorization, if approved, would be effective for a twelve-month period from the Special Meeting date. The Special Meeting will be held virtually on August 13, 2026; the record date is May 12, 2026. The proposal is described as a precautionary flexibility measure for use during periods of market disruption, subject to board determinations and conditions mandated by the Investment Company Act.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

Ares Capital Corporation (ARCC) filed a prospectus supplement for an at-the-market equity offering under separate equity distribution agreements to sell up to $1,500,000,000 of common stock through designated sales agents. The offering permits sales from time to time on Nasdaq and other trading venues under commercially reasonable terms, with sales-agent compensation up to 1.50% of gross proceeds. The prospectus states the company may use net proceeds to repay outstanding indebtedness and for general corporate purposes, and that sales prices will not be less than the then-current net asset value per share except with board or stockholder approval.

The supplement provides context on ARCC’s business as a closed-end BDC, portfolio focus, key financing facilities, shares outstanding of 718,022,845 as of April 23, 2026, a net asset value per share of $19.59 as of March 31, 2026, and an April 27, 2026 close price of $18.61.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

Ares Capital Corporation entered new equity distribution agreements that allow it to issue and sell shares of its common stock with an aggregate offering price of up to $1,500,000,000 through multiple sales agents. These shares may be sold in negotiated deals or “at the market” transactions on the NASDAQ Global Select Market or through market makers at prices tied to prevailing or negotiated levels.

The sales agents, including Truist, Mizuho, RBC, Regions and SMBC, may earn commissions of up to 1.5% of the gross sales price of any shares sold. The company is not obligated to sell any shares and can suspend offerings at any time. On the same date, Ares Capital terminated prior equity distribution agreements from February 5, 2025 that have been superseded by these new arrangements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

Ares Capital Corporation reported first quarter 2026 results and declared a second quarter 2026 dividend of $0.48 per share, payable June 30, 2026 to stockholders of record on June 15, 2026.

For the quarter ended March 31, 2026, GAAP net income was $92 million, or $0.13 per share, compared with $241 million, or $0.36 per share, a year earlier, mainly reflecting higher net unrealized losses of $412 million. Net investment income increased to $398 million, or $0.55 per share, from $365 million, or $0.54 per share, while Core EPS was $0.47 versus $0.50.

Portfolio investments at fair value were $29.5 billion as of March 31, 2026, and net asset value per share was $19.59, slightly below $19.94 as of December 31, 2025. The debt/equity ratio was 1.13x, and loans on non-accrual status remained low at 2.1% of total investments at amortized cost and 1.2% at fair value.

Ares Capital highlighted approximately $6.0 billion of available liquidity, including $505 million of cash and $5.5 billion of capacity under credit facilities. During the quarter it issued $750 million of unsecured notes due 2031 at 5.250%, repaid $1,150 million of maturing 3.875% notes, and expanded its SMBC revolving funding facility from $1.1 billion to $1.6 billion while modestly reducing spreads.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Ares Capital Corporation filed an Amendment No. 1 to its Annual Report on Form 10-K for the year ended December 31, 2025. The main purpose is to add separate audited consolidated financial statements for Ivy Hill Asset Management, L.P. (IHAM), an unconsolidated, wholly owned portfolio company that now qualifies as a significant subsidiary under Regulation S-X.

The Amendment includes IHAM’s audited financial statements as Exhibit 99.3 and updates Part IV, Item 15 to reflect these materials. It also adds new CEO and CFO certification exhibits (31.1, 31.2 and 32.1) and a new auditor consent (Exhibit 23.2). Other disclosures from the original Form 10-K remain unchanged and are not updated for subsequent events or new forward-looking information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report
-
Rhea-AI Summary

Ares Capital Corporation is asking stockholders to vote at its 2026 virtual annual meeting on May 7, 2026 at 4:00 p.m. Eastern Time. Investors will elect three Class I directors—Ann Torre Bates, Steven B. McKeever and Michael J Arougheti—to serve until the 2029 annual meeting and vote on ratifying KPMG LLP as independent registered public accounting firm for the year ending December 31, 2026.

The meeting is fully virtual via www.virtualshareholdermeeting.com/ARCC2026 for holders of NASDAQ: ARCC common stock of record as of March 2, 2026. The proxy statement outlines a staggered board with a majority of independent directors, committee structures, and management biographies, and notes 718,022,845 shares outstanding and entitled to vote as of the record date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

Ares Capital Corporation updated a key borrowing facility with Sumitomo Mitsui Banking Corporation and other lenders. The amendment increases total commitments under the SMBC Funding Facility from $1.1 billion to $1.6 billion, giving the company more committed debt capacity for its lending activities.

The pricing on the facility improves slightly, with the applicable spread reduced from 1.80% to 1.75% over SOFR, or from 0.80% to 0.75% over a defined base rate. The amendment also expands the accordion feature, allowing potential upsizing of the facility’s maximum size from $1.3 billion to $2.5 billion under certain conditions, while other terms remain materially unchanged.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Ares Capital Corporation’s Chief Operating Officer, Jana Markowicz, reported a purchase of company stock. On 02/09/2026, she acquired 15,000 shares of Ares Capital common stock at a price of $19.20 per share. Following this transaction, she beneficially owns 25,176 shares held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Ares Capital (ARCC) SEC filings are available on StockTitan?

StockTitan tracks 30 SEC filings for Ares Capital (ARCC), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Ares Capital (ARCC)?

The most recent SEC filing for Ares Capital (ARCC) was filed on May 4, 2026.